Channel Therapeutics Corporation
Research Channel Therapeutics Corporation (PTHS) on Bullrun: market cap USD 92.84M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerPTHS
- ExchangeNYSE MKT
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 92.84M
- Financial periodFY2025
- RevenueUSD 16.80M
- Net income-USD 43.32M
- Free cash flow-USD 22.69M
- Gross margin76.3%
Valuation Snapshot
latest market cap is USD 92.84M.
About Channel Therapeutics Corporation
Pelthos Therapeutics Inc., a bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens. The company offers ZELSUVMI for the treatment of molluscum contagiosum in adults and children 1 year of age and older; XEPI, (ozenoxacin) cream, a quinolone antimicrobial for the treatment of impetigo due to Staphylococcus aureus or Streptococcus pyogenes in adult and pediatric patients 2 months of age and older;
Frequently asked questions
What is Channel Therapeutics Corporation's market cap?
Channel Therapeutics Corporation's market capitalization is USD 92.84M.
What does Channel Therapeutics Corporation do?
Pelthos Therapeutics Inc., a bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens. The company offers ZELSUVMI for the treatment of molluscum contagiosum in adults and children 1 year of age and older;